Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives

Coronavirus disease 2019 (COVID-19) is a global infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Approximately 15% of severe cases require an intensive care unit (ICU) admission and mechanical ventilation due to development of acute respiratory distress synd...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Alqarni, Mohammed, Cruz-Martins, Natália, El-Saber Batiha, Gaber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103613/
https://www.ncbi.nlm.nih.gov/pubmed/33967777
http://dx.doi.org/10.3389/fphar.2021.642822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103613/
https://www.ncbi.nlm.nih.gov/pubmed/33967777
http://dx.doi.org/10.3389/fphar.2021.642822

Ejemplares similares